Gemfibrozil

CAS: 25812-30-0

Ref. TR-G305750

Produktinformation

• Name: Gemfibrozil
• Synonyme: 2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid, 5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid, CI 719, Decrelip, Genlip, Gevilon, Lipur, Lopid, Lopizid, Trialmin 900, 2,2-Dimethyl-5-(2,5-dimethylphenoxy)pentanoic acid, 2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure, 2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure, 5-[(2,5-Dimethylphenyl)oxy]-2,2-dimethylpentanoic acid, Apo-Gemfibrozil, Ausgem, Bolutol, Brn 1881200, Brozil, Ccris 318, Cholespid, Ci 719, Clearol, Elmogan, Fetinor, Fibratol, Fibrocit, Gem-S, Gemd, Gemfibril, Gemfibromax, Gemfibrozil [USAN:INN:BAN], Gemfibrozilo, Gemfibrozilo [INN-Spanish], Gemfibrozilum, Gemfibrozilum [INN-Latin], Gemlipid, Gemnpid, Gevilon Uno, Gozid, Hidil, Hipolixan, Hsdb 7735, Innogen, Ipolipid, Jezil, Lanaterom, Lifibron, Lipazil, Lipigem, Lipira, Lipizyl, Litarek, Low-Lip, Micolip, Normolip, Pentanoic acid, 5-(2,5-dimethylphenoxy)-2,2-dimethyl-, Pilder, Polyxit, Progemzal, Reducel, Regulip, Renabrazin, Sinelip, Synbrozil, Taborcil, Tentroc, Trialmin, Unii-Q8X02027X3, Valeric acid, 2,2-dimethyl-5-(2,5-xylyloxy)-, WL-Gemfibrozil

Beschreibung

Applications A serum lipid regulating agent used as an antihyperlipoproteinemic.This compound is a contaminant of emerging concern (CECs).
References Kissebach, A.H., et al.: Atherosclerosis, 24, 199 (1976), Lewis, J.E., et al.: Pract. Cardiol., 9, 99 (1983), Rubins, H.B., et al.: N. Engl. J. Med., 341, 410 (1999)

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 250.33
• Formel: C₁₅H₂₂O₃
• Farbe/Form: White
• InChl: InChI=1S/C15H22O3/c1-11-6-7-12(2)13(10-11)18-9-5-8-15(3,4)14(16)17/h6-7,10H,5,8-9H2,1-4H3,(H,16,17)
• InChI Key: InChIKey=HEMJJKBWTPKOJG-UHFFFAOYSA-N
• SMILES: Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1